CTLA4 and myeloid sarcoma: In addition, Boćko et al. showed that the distribution of CTLA-4 exon 1 A(49)G genotype, phenotype, and allele frequencies was not different when comparing healthy controls with unrelated Polish MS patients in the Lower Silesia region [143].